HC Wainwright Has Lowered Expectations for Curis (NASDAQ:CRIS) Stock Price
Curis (NASDAQ:CRIS – Get Free Report) had its price objective dropped by investment analysts at HC Wainwright from $20.00 to $16.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Separately, StockNews.com started coverage on Curis in a research note on Saturday. They issued a […]
Curis (NASDAQ:CRIS – Get Free Report) had its price objective dropped by investment analysts at HC Wainwright from $20.00 to $16.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Separately, StockNews.com started coverage on Curis in a research note on Saturday. They issued a […]
